Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Peregrine Pharma New (PPHM)

0.55 +0.11 (+24.07%)

2/17/2017  4:00pm

Open:

0.45

Pre. Close:

0.44

High:

0.66

Low:

0.45

Volume:

27,005,991

Market Cap:

141.43M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.65 - 0.7

0.7 - 0.76

Low:

0.4 - 0.42

0.42 - 0.45

Close:

0.51 - 0.55

0.55 - 0.61

Technical analysis  (as of: 2017-02-17 4:35:10 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.77     One year: 0.90

Support:

Support1: 0.43    Support2: 0.28

Resistance:

Resistance1: 0.66    Resistance2: 0.77

Pivot:

0.35

Moving Averages:

MA(5): 0.42     MA(20): 0.34

MA(100): 0.33     MA(250): 0.37

MACD:

MACD(12,26): 0.04     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 86.14     %D(3): 89.57

RSI:

RSI(14): 91.07

52-Week:

High: 1.12  Low: 0.28  Change(%): -47.6

Average Vol(K):

3-Month: 2713  10-Days 6113

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PPHM has closed It is unclear right now based on current numbers. 230.5% wider than normal. The large width of the bands suggest high volatility as compared to PPHM's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Sun, 12 Feb 2017 10:18:45 GMT
Peregrine Pharmaceuticals (NASDAQ:PPHM): Partnership Is Next In Play

Fri, 17 Feb 2017 17:21:24 GMT
Peregrine Pharmaceuticals (PPHM) Stock: Gains Big On Data

Thu, 15 Dec 2016 18:33:45 GMT
Peregrine Pharmaceuticals Reported Stellar Quarterly Results - So Why Did The ...

Fri, 10 Feb 2017 07:30:00 GMT
Can the Rally in Peregrine Pharmaceuticals (PPHM) Shares Continue? February 10 ...

Tue, 24 Jan 2017 11:15:00 GMT
Peregrine Pharmaceuticals (PPHM) Sees Hammer Chart Pattern: Time to Buy ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

257.14

Shares Float (M)

229.46

% Held by Insiders

4.45

% Held by Institutions

17.60

Shares Short (K)

788

Shares Short Prior Month (K)

685

Stock Financials

EPS

-0.200

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.170

PEG Ratio

Profit Margin

-80.49

Operating Margin

-80.67

Return on Assets (ttm)

-24.7

Return on Equity (ttm)

-78.7

Qtrly Rev. Growth

145.4

Gross Profit (p.s.)

0.084

Sales Per Share

0.212

EBITDA (p.s.)

-0.162

Qtrly Earnings Growth

Operating Cash Flow (M)

-29.80

Levered Free Cash Flow (M)

-18.93

FoxReading.com

Valuation

P/E

-2.75

P/E Growth Ratio

0.24

P/BV

3.24

P/S

2.60

P/CF

-4.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.